Escitalopram vs Pembrolizumab

Escitalopram vs Pembrolizumab: Overview

This comparison examines the pharmacological differences between Escitalopram and Pembrolizumab.

Mechanism of Action

Escitalopram: S-enantiomer of citalopram; selective serotonin reuptake inhibitor.

Pembrolizumab: Anti-PD-1 monoclonal antibody restoring anti-tumor immunity.

Pharmacokinetics

Half-life: Escitalopram — 27-32 hours; Pembrolizumab — 26 days.

Chemical Properties

Molecular Formula: Escitalopram — C20H21FN2O.

Molecular Weight: Escitalopram — 324.3920 g/mol.

Type: Escitalopram — Small molecule; Pembrolizumab — Antibody.